25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Mymetics Corp
Buy, Hold or Sell?

Let's analyze Mymetics together

I guess you are interested in Mymetics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mymetics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Mymetics Corp

I send you an email if I find something interesting about Mymetics Corp.

1. Quick Overview

1.1. Quick analysis of Mymetics (30 sec.)










1.2. What can you expect buying and holding a share of Mymetics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-448.74
Expected worth in 1 year
$-2,242.86
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
$-1,794.12
Return On Investment
-179,411,842.3%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.001 - $0.001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Mymetics (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-172.53 - $-62.28
Total Value Per Share
$-621.27 - $-511.02

2.2. Growth of Mymetics (5 min.)




Is Mymetics growing?

Current yearPrevious yearGrowGrow %
How rich?-$68.1m-$63.1m-$5m-7.4%

How much money is Mymetics making?

Current yearPrevious yearGrowGrow %
Making money-$5m-$7.5m$2.4m48.8%
Net Profit Margin-160,166.7%-238,400.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Mymetics (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Mymetics?

Welcome investor! Mymetics's management wants to use your money to grow the business. In return you get a share of Mymetics.

First you should know what it really means to hold a share of Mymetics. And how you can make/lose money.

Speculation

The Price per Share of Mymetics is $0.001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mymetics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mymetics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-448.74. Based on the TTM, the Book Value Change Per Share is $-448.53 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mymetics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-33.23-3,322,520.6%-33.23-3,322,520.6%-0.02-1,635.3%-6.66-665,696.7%-3.33-333,128.6%
Usd Book Value Change Per Share-448.53-44,852,960.6%-448.53-44,852,960.6%-0.02-1,636.7%-89.72-8,971,782.0%-44.86-4,486,186.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-448.53-44,852,960.6%-448.53-44,852,960.6%-0.02-1,636.7%-89.72-8,971,782.0%-44.86-4,486,186.1%
Usd Price Per Share0.03-0.03-0.03-0.05-0.03-
Price to Earnings Ratio0.00-0.00--1.95--2.77--1.97-
Price-to-Total Gains Ratio0.00-0.00--1.95--2.77--2.08-
Price to Book Ratio0.00-0.00--0.15--0.22--0.19-
Price-to-Total Gains Ratio0.00-0.00--1.95--2.77--2.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.001
Number of shares1000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-448.53-89.72
Usd Total Gains Per Share-448.53-89.72
Gains per Quarter (1000000 shares)-448,529,605.82-89,717,820.02
Gains per Year (1000000 shares)-1,794,118,423.27-358,871,280.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1794118423-17941184330-358871280-358871290
20-3588236847-35882368560-717742560-717742570
30-5382355270-53823552790-1076613840-1076613850
40-7176473693-71764737020-1435485120-1435485130
50-8970592116-89705921250-1794356400-1794356410
60-10764710540-107647105480-2153227680-2153227690
70-12558828963-125588289710-2512098961-2512098970
80-14352947386-143529473940-2870970241-2870970250
90-16147065809-161470658170-3229841521-3229841530
100-17941184233-179411842400-3588712801-3588712810

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.022.00.04.3%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%7.016.00.030.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.022.04.3%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%7.016.00.030.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Mymetics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---448.530-448.5300%-0.016-100%-89.718-80%-44.862-90%
Book Value Per Share---448.737-448.7370%-0.208-100%-89.895-80%-45.007-90%
Current Ratio--0.0070.0070%0.010-33%0.014-54%0.034-80%
Debt To Asset Ratio--9.8649.8640%8.873+11%8.252+20%6.385+54%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---75509024.430-75509024.4300%-60827911.258-19%-53600007.648-29%-46678447.988-38%
Eps---33.225-33.2250%-0.016-100%-6.657-80%-3.331-90%
Ev To Ebitda Ratio--36.13036.1300%29.551+22%30.734+18%55.112-34%
Ev To Sales Ratio---23966.554-23966.5540%-19306.771-19%-9069.059-62%-4543.941-81%
Free Cash Flow Per Share---11.679-11.6790%-0.006-100%-2.340-80%-1.172-90%
Free Cash Flow To Equity Per Share---1.749-1.7490%-0.002-100%-0.350-80%-0.172-90%
Gross Profit Margin--1.0361.0360%1.000+4%1.007+3%1.004+3%
Intrinsic Value_10Y_max---62.283--------
Intrinsic Value_10Y_min---172.533--------
Intrinsic Value_1Y_max---2.270--------
Intrinsic Value_1Y_min---7.348--------
Intrinsic Value_3Y_max---9.846--------
Intrinsic Value_3Y_min---30.818--------
Intrinsic Value_5Y_max---21.072--------
Intrinsic Value_5Y_min---63.689--------
Market Cap151.878-2900%4556.3704556.3700%9689868.142-100%12345621.032-100%9093368.192-100%
Net Profit Margin---1601.667-1601.6670%-2384.000+49%-839.563-48%-420.623-74%
Operating Margin---668.333-668.3330%-550.000-18%-259.213-61%-129.499-81%
Operating Ratio--582.667582.6670%551.000+6%242.731+140%122.401+376%
Pb Ratio0.000+97%0.0000.0000%-0.154+229591%-0.223+333205%-0.193+288793%
Pe Ratio0.000+97%-0.001-0.0010%-1.951+215938%-2.767+306371%-1.971+218203%
Price Per Share0.001-2900%0.0300.0300%0.032-6%0.047-36%0.033-9%
Price To Free Cash Flow Ratio0.000+97%-0.003-0.0030%-5.402+210201%-7.354+286179%-3.617+140726%
Price To Total Gains Ratio0.000+97%0.0000.0000%-1.949+2913886%-2.774+4147306%-2.084+3115732%
Quick Ratio--0.0050.0050%0.009-40%0.013-60%0.033-84%
Return On Assets---0.656-0.6560%-0.937+43%-0.637-3%-0.451-31%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---448.530-448.5300%-0.016-100%-89.718-80%-44.862-90%
Usd Book Value---68153779.200-68153779.2000%-63102317.200-7%-58508112.280-14%-47289665.840-31%
Usd Book Value Change Per Share---448.530-448.5300%-0.016-100%-89.718-80%-44.862-90%
Usd Book Value Per Share---448.737-448.7370%-0.208-100%-89.895-80%-45.007-90%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---75509024.430-75509024.4300%-60827911.258-19%-53600007.648-29%-46678447.988-38%
Usd Eps---33.225-33.2250%-0.016-100%-6.657-80%-3.331-90%
Usd Free Cash Flow---1773787.800-1773787.8000%-1793741.600+1%-1770217.1200%-1336484.520-25%
Usd Free Cash Flow Per Share---11.679-11.6790%-0.006-100%-2.340-80%-1.172-90%
Usd Free Cash Flow To Equity Per Share---1.749-1.7490%-0.002-100%-0.350-80%-0.172-90%
Usd Market Cap151.878-2900%4556.3704556.3700%9689868.142-100%12345621.032-100%9093368.192-100%
Usd Price Per Share0.001-2900%0.0300.0300%0.032-6%0.047-36%0.033-9%
Usd Profit---5046211.000-5046211.0000%-7511030.400+49%-5140518.960+2%-3655641.180-28%
Usd Revenue--3150.6003150.6000%3150.6000%47679.080-93%1357488.520-100%
Usd Total Gains Per Share---448.530-448.5300%-0.016-100%-89.718-80%-44.862-90%
 EOD+2 -6MRQTTM+0 -0YOY+8 -275Y+5 -3110Y+3 -33

3.3 Fundamental Score

Let's check the fundamental score of Mymetics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-1,601.667
Operating Margin (MRQ)Greater than0-668.333
Quick Ratio (MRQ)Greater than10.005
Current Ratio (MRQ)Greater than10.007
Debt to Asset Ratio (MRQ)Less than19.864
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.656
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Mymetics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5012.472
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Mymetics Corp

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Fundamental data was last updated by Penke on 2024-12-06 13:46:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Mymetics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Mymetics to the Biotechnology industry mean.
  • A Net Profit Margin of -160,166.7% means that $-1,601.67 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mymetics Corp:

  • The MRQ is -160,166.7%. The company is making a huge loss. -2
  • The TTM is -160,166.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-160,166.7%TTM-160,166.7%0.0%
TTM-160,166.7%YOY-238,400.0%+78,233.3%
TTM-160,166.7%5Y-83,956.3%-76,210.4%
5Y-83,956.3%10Y-42,062.3%-41,894.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-160,166.7%-109.4%-160,057.3%
TTM-160,166.7%-221.4%-159,945.3%
YOY-238,400.0%-208.7%-238,191.3%
5Y-83,956.3%-346.2%-83,610.1%
10Y-42,062.3%-470.4%-41,591.9%
4.3.1.2. Return on Assets

Shows how efficient Mymetics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mymetics to the Biotechnology industry mean.
  • -65.6% Return on Assets means that Mymetics generated $-0.66 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mymetics Corp:

  • The MRQ is -65.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -65.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-65.6%TTM-65.6%0.0%
TTM-65.6%YOY-93.7%+28.1%
TTM-65.6%5Y-63.7%-1.9%
5Y-63.7%10Y-45.1%-18.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-65.6%-11.6%-54.0%
TTM-65.6%-12.0%-53.6%
YOY-93.7%-11.2%-82.5%
5Y-63.7%-12.6%-51.1%
10Y-45.1%-14.1%-31.0%
4.3.1.3. Return on Equity

Shows how efficient Mymetics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mymetics to the Biotechnology industry mean.
  • 0.0% Return on Equity means Mymetics generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mymetics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.6%+14.6%
TTM--16.1%+16.1%
YOY--14.6%+14.6%
5Y--18.5%+18.5%
10Y--19.3%+19.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Mymetics Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Mymetics is operating .

  • Measures how much profit Mymetics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mymetics to the Biotechnology industry mean.
  • An Operating Margin of -66,833.3% means the company generated $-668.33  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mymetics Corp:

  • The MRQ is -66,833.3%. The company is operating very inefficient. -2
  • The TTM is -66,833.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-66,833.3%TTM-66,833.3%0.0%
TTM-66,833.3%YOY-55,000.0%-11,833.3%
TTM-66,833.3%5Y-25,921.3%-40,912.0%
5Y-25,921.3%10Y-12,949.9%-12,971.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-66,833.3%-204.6%-66,628.7%
TTM-66,833.3%-316.3%-66,517.0%
YOY-55,000.0%-216.5%-54,783.5%
5Y-25,921.3%-378.6%-25,542.7%
10Y-12,949.9%-480.3%-12,469.6%
4.3.2.2. Operating Ratio

Measures how efficient Mymetics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 582.67 means that the operating costs are $582.67 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Mymetics Corp:

  • The MRQ is 582.667. The company is inefficient in keeping operating costs low. -1
  • The TTM is 582.667. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ582.667TTM582.6670.000
TTM582.667YOY551.000+31.667
TTM582.6675Y242.731+339.935
5Y242.73110Y122.401+120.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ582.6672.284+580.383
TTM582.6673.198+579.469
YOY551.0003.263+547.737
5Y242.7314.651+238.080
10Y122.4016.419+115.982
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Mymetics Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Mymetics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.01 means the company has $0.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Mymetics Corp:

  • The MRQ is 0.007. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.007. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.007TTM0.0070.000
TTM0.007YOY0.010-0.003
TTM0.0075Y0.014-0.008
5Y0.01410Y0.034-0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0073.596-3.589
TTM0.0073.869-3.862
YOY0.0104.644-4.634
5Y0.0145.971-5.957
10Y0.0346.240-6.206
4.4.3.2. Quick Ratio

Measures if Mymetics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mymetics to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mymetics Corp:

  • The MRQ is 0.005. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.005. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.005TTM0.0050.000
TTM0.005YOY0.009-0.003
TTM0.0055Y0.013-0.008
5Y0.01310Y0.033-0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0053.090-3.085
TTM0.0053.413-3.408
YOY0.0094.349-4.340
5Y0.0135.953-5.940
10Y0.0336.435-6.402
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Mymetics Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Mymetics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mymetics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 9.86 means that Mymetics assets are financed with 986.4% credit (debt) and the remaining percentage (100% - 986.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mymetics Corp:

  • The MRQ is 9.864. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 9.864. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ9.864TTM9.8640.000
TTM9.864YOY8.873+0.991
TTM9.8645Y8.252+1.612
5Y8.25210Y6.385+1.867
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8640.346+9.518
TTM9.8640.347+9.517
YOY8.8730.313+8.560
5Y8.2520.365+7.887
10Y6.3850.383+6.002
4.5.4.2. Debt to Equity Ratio

Measures if Mymetics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mymetics to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mymetics Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.432-0.432
YOY-0.385-0.385
5Y-0.455-0.455
10Y-0.498-0.498
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Mymetics generates.

  • Above 15 is considered overpriced but always compare Mymetics to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mymetics Corp:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.001. Based on the earnings, the company is expensive. -2
  • The TTM is -0.001. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.001+0.001
MRQ-0.001TTM-0.0010.000
TTM-0.001YOY-1.951+1.950
TTM-0.0015Y-2.767+2.766
5Y-2.76710Y-1.971-0.796
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.323+2.323
MRQ-0.001-2.493+2.492
TTM-0.001-3.148+3.147
YOY-1.951-3.251+1.300
5Y-2.767-5.992+3.225
10Y-1.971-6.690+4.719
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mymetics Corp:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.003. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.003. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.003+0.002
MRQ-0.003TTM-0.0030.000
TTM-0.003YOY-5.402+5.399
TTM-0.0035Y-7.354+7.351
5Y-7.35410Y-3.617-3.736
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-3.079+3.079
MRQ-0.003-3.295+3.292
TTM-0.003-3.671+3.668
YOY-5.402-4.475-0.927
5Y-7.354-8.015+0.661
10Y-3.617-9.197+5.580
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Mymetics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Mymetics Corp:

  • The EOD is 0.000. Based on the equity, the company is expensive. -2
  • The MRQ is 0.000. Based on the equity, the company is expensive. -2
  • The TTM is 0.000. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.000+0.000
MRQ0.000TTM0.0000.000
TTM0.000YOY-0.154+0.153
TTM0.0005Y-0.223+0.223
5Y-0.22310Y-0.193-0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0002.022-2.022
MRQ0.0002.054-2.054
TTM0.0002.386-2.386
YOY-0.1542.442-2.596
5Y-0.2233.696-3.919
10Y-0.1934.311-4.504
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Tax Provision  203233264066-122-56



6.2. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets7,321
Total Liabilities72,217
Total Stockholder Equity-64,896
 As reported
Total Liabilities 72,217
Total Stockholder Equity+ -64,896
Total Assets = 7,321

Assets

Total Assets7,321
Total Current Assets481
Long-term Assets6,840
Total Current Assets
Cash And Cash Equivalents 313
Net Receivables 62
Other Current Assets 106
Total Current Assets  (as reported)481
Total Current Assets  (calculated)481
+/-0
Long-term Assets
Property Plant Equipment 159
Goodwill 6,671
Other Assets 10
Long-term Assets  (as reported)6,840
Long-term Assets  (calculated)6,840
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities72,030
Long-term Liabilities187
Total Stockholder Equity-64,896
Total Current Liabilities
Short-term Debt 71,810
Short Long Term Debt 71,704
Accounts payable 213
Other Current Liabilities 993
Total Current Liabilities  (as reported)72,030
Total Current Liabilities  (calculated)144,720
+/- 72,690
Long-term Liabilities
Capital Lease Obligations 137
Long-term Liabilities  (as reported)187
Long-term Liabilities  (calculated)137
+/- 50
Total Stockholder Equity
Common Stock2,530
Retained Earnings -102,555
Accumulated Other Comprehensive Income 686
Other Stockholders Equity 34,443
Total Stockholder Equity (as reported)-64,896
Total Stockholder Equity (calculated)-64,896
+/-0
Other
Capital Stock2,530
Cash and Short Term Investments 313
Common Stock Shares Outstanding 152
Current Deferred Revenue7
Liabilities and Stockholders Equity 7,321
Net Debt 71,684
Net Invested Capital 6,964
Net Tangible Assets -71,567
Net Working Capital -71,549
Property Plant and Equipment Gross 634
Short Long Term Debt Total 71,997



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
> Total Assets 
2,800
2,660
220
1,695
477
366
124
106
224
192
674
14,757
13,311
9,483
9,346
13,120
11,010
11,708
8,340
8,042
7,808
7,682
8,096
7,632
7,321
7,3217,6328,0967,6827,8088,0428,34011,70811,01013,1209,3469,48313,31114,7576741922241061243664771,6952202,6602,800
   > Total Current Assets 
2,800
2,300
220
1,324
278
230
72
73
37
192
598
3,038
1,941
497
381
4,066
1,944
2,665
1,602
1,306
1,101
932
1,239
673
481
4816731,2399321,1011,3061,6022,6651,9444,0663814971,9413,0385981923773722302781,3242202,3002,800
       Cash And Cash Equivalents 
40
2,250
213
889
183
125
0
45
18
96
509
2,959
1,811
382
286
297
1,614
2,381
1,391
1,180
479
683
1,083
571
313
3135711,0836834791,1801,3912,3811,6142972863821,8112,95950996184501251838892132,25040
       Short-term Investments 
0
0
0
355
0
0
0
0
0
36
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003600000355000
       Net Receivables 
2,250
60
7
49
59
100
71
27
9
43
14
45
100
61
43
3,712
278
218
170
90
585
154
71
15
62
621571154585901702182783,71243611004514439277110059497602,250
       Other Current Assets 
510
-10
0
-1
36
-1
1
2
0
16
75
34
30
54
52
57
52
66
41
36
37
85
85
87
106
106878585373641665257525430347516021-136-10-10510
   > Long-term Assets 
0
360
0
371
199
136
52
33
186
0
76
11,719
11,370
8,986
8,965
9,054
9,066
9,043
6,738
6,736
6,707
6,750
6,857
6,959
6,840
6,8406,9596,8576,7506,7076,7366,7389,0439,0669,0548,9658,98611,37011,719760186335213619937103600
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
76
232
76
49
28
117
129
106
67
65
36
79
176
278
159
15927817679366567106129117284976232760000000000
       Goodwill 
0
0
0
186
0
0
0
0
0
0
0
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,671
6,6716,6716,6716,6716,6716,6716,6716,6716,6716,6716,6716,6716,6716,6710000000186000
       Intangible Assets 
0
0
0
371
199
136
52
34
186
0
0
4,816
4,623
2,266
2,266
12,314
2,266
2,266
3,319,291,335
1,000,000,000,000,000
0
0
0
0
0
000001,000,000,000,000,0003,319,291,3352,2662,26612,3142,2662,2664,6234,816001863452136199371000
       Other Assets 
0
0
0
143
0
0
0
0
0
0
0
0
0
0
0
0
2,266
0
0
0
0
10
10
10
10
1010101000002,266000000000000143000
> Total Liabilities 
970
30
114
1,000
2,828
4,759
3,398
4,142
4,251
2,731
9,989
33,572
34,678
37,822
42,581
40,217
41,099
44,600
47,119
50,920
54,833
58,880
63,448
67,718
72,217
72,21767,71863,44858,88054,83350,92047,11944,60041,09940,21742,58137,82234,67833,5729,9892,7314,2514,1423,3984,7592,8281,00011430970
   > Total Current Liabilities 
970
30
114
759
2,586
4,517
1,388
3,962
4,102
2,640
1,016
7,321
5,238
6,738
36,048
40,217
41,099
44,600
47,119
50,920
54,833
58,853
63,265
67,426
72,030
72,03067,42663,26558,85354,83350,92047,11944,60041,09940,21736,0486,7385,2387,3211,0162,6404,1023,9621,3884,5172,58675911430970
       Short-term Debt 
0
0
0
228
1,991
3,121
323
2,412
2,718
1,211
0
5,740
3,872
5,711
34,723
39,123
40,374
43,170
45,834
50,409
54,758
58,788
63,195
67,379
71,810
71,81067,37963,19558,78854,75850,40945,83443,17040,37439,12334,7235,7113,8725,74001,2112,7182,4123233,1211,991228000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,123
40,374
50,916
45,834
50,409
54,758
58,686
63,090
67,269
71,704
71,70467,26963,09058,68654,75850,40945,83450,91640,37439,123000000000000000
       Accounts payable 
10
30
114
437
453
1,230
964
1,347
1,202
1,396
991
1,540
1,340
1,025
1,325
858
725
332
120
237
75
167
70
47
213
2134770167752371203327258581,3251,0251,3401,5409911,3961,2021,3479641,2304534371143010
       Other Current Liabilities 
960
0
0
93
143
166
100
203
183
34
25
41
26
2
10,107
236
15,377
1,295
1,165
274
0
-102
34,730
35,540
993
99335,54034,730-10202741,1651,29515,37723610,1072264125341832031001661439300960
   > Long-term Liabilities 
10
30
114
242
242
241
2,010
181
149
91
8,973
26,251
29,440
31,084
6,533
39,981
41,099
44,600
47,119
50,920
54,833
27
183
292
187
1872921832754,83350,92047,11944,60041,09939,9816,53331,08429,44026,2518,973911491812,0102412422421143010
       Other Liabilities 
0
0
0
215
254
305
327
287
320
0
0
2,775
9,417
14,577
8,615
0
0
0
0
0
0
0
0
0
0
00000000008,61514,5779,4172,77500320287327305254215000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,266
0
0
0
0
0
0
0
0
000000002,2660000000000000000
> Total Stockholder Equity
1,830
2,630
106
695
-2,351
-4,393
-3,274
-4,036
-4,028
-2,539
-9,315
-18,815
-21,367
-28,339
-33,235
-27,097
-30,089
-32,892
-38,779
-42,878
-47,025
-51,198
-55,352
-60,086
-64,896
-64,896-60,086-55,352-51,198-47,025-42,878-38,779-32,892-30,089-27,097-33,235-28,339-21,367-18,815-9,315-2,539-4,028-4,036-3,274-4,393-2,3516951062,6301,830
   Common Stock
40
50
87
563
579
606
465
500
661
1,025
1,742
1,754
1,888
2,322
2,468
2,491
2,530
2,530
2,530
2,530
2,530
2,530
2,530
2,530
2,530
2,5302,5302,5302,5302,5302,5302,5302,5302,5302,4912,4682,3221,8881,7541,7421,025661500465606579563875040
   Retained Earnings -102,555-97,750-93,020-88,862-84,675-80,503-76,391-70,427-67,421-64,165-70,168-64,057-53,518-42,090-31,904-15,108-9,743-9,053-7,853-23,757-21,032-17,422-10,078-8,400-6,810
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000-7100
   Other Stockholders Equity 
8,600
10,980
10,097
17,453
17,904
18,110
3,570
4,002
4,589
11,137
20,162
20,840
29,602
32,732
33,783
33,876
34,169
34,315
34,392
34,428
34,441
34,443
34,443
34,443
34,443
34,44334,44334,44334,44334,44134,42834,39234,31534,16933,87633,78332,73229,60220,84020,16211,1374,5894,0023,57018,11017,90417,45310,09710,9808,600



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue6
Cost of Revenue-1,105
Gross Profit-1,099-1,099
 
Operating Income (+$)
Gross Profit-1,099
Operating Expense-2,445
Operating Income-2,439-3,544
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,867
Selling And Marketing Expenses-
Operating Expense2,4451,867
 
Net Interest Income (+$)
Interest Income-
Interest Expense-2,822
Other Finance Cost-0
Net Interest Income-2,822
 
Pretax Income (+$)
Operating Income-2,439
Net Interest Income-2,822
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,5673,867
EBIT - interestExpense = -2,822
-11,567
-8,745
Interest Expense2,822
Earnings Before Interest and Taxes (EBIT)--8,745
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-11,567
Tax Provision-0
Net Income From Continuing Ops-11,567-11,567
Net Income-11,567
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-6,3062,822
 

Technical Analysis of Mymetics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mymetics. The general trend of Mymetics is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mymetics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mymetics Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.001 < 0.001 < 0.001.

The bearish price targets are: 0.001 > 0.001 > 0.001.

Tweet this
Mymetics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mymetics Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mymetics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mymetics Corp. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mymetics price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Mymetics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Mymetics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mymetics Corp Daily Moving Average Convergence/Divergence (MACD) ChartMymetics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mymetics Corp. The current adx is 75.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Mymetics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Mymetics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mymetics Corp. The current sar is 0.00100027.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Mymetics Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mymetics Corp. The current rsi is 12.47. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Mymetics Corp Daily Relative Strength Index (RSI) ChartMymetics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mymetics Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mymetics price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Mymetics Corp Daily Stochastic Oscillator ChartMymetics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mymetics Corp. The current cci is -66.66666667.

Mymetics Corp Daily Commodity Channel Index (CCI) ChartMymetics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mymetics Corp. The current cmo is 0.

Mymetics Corp Daily Chande Momentum Oscillator (CMO) ChartMymetics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mymetics Corp. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Mymetics Corp Daily Williams %R ChartMymetics Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mymetics Corp.

Mymetics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mymetics Corp. The current atr is 0.0000.

Mymetics Corp Daily Average True Range (ATR) ChartMymetics Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mymetics Corp. The current obv is -6,542,348.

Mymetics Corp Daily On-Balance Volume (OBV) ChartMymetics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mymetics Corp. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Mymetics Corp Daily Money Flow Index (MFI) ChartMymetics Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mymetics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Mymetics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mymetics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5012.472
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Mymetics with someone you think should read this too:
  • Are you bullish or bearish on Mymetics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mymetics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mymetics Corp

I send you an email if I find something interesting about Mymetics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Mymetics Corp.

Receive notifications about Mymetics Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.